CD33 and amyloidosis: Accordingly, initial studies performed using an amyloidosis mouse model deficient for Cd33 led to the conclusion that decreased signalling via CD33 induces a protective response that is associated with overall lower soluble and insoluble Aβ levels in brain, most likely due to improved microglial activity [147].